- Tecan Group AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Half Year 2023 Tecan Group AG Earnings Call TranscriptAug 15, 2023CHF365.64 (+9.26%)Earnings
- Full Year 2022 Tecan Group AG Earnings Call TranscriptMar 14, 2023CHF391.32 (+5.43%)Earnings
- Tecan Group AG at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Half Year 2022 Tecan Group AG Earnings Call TranscriptAug 17, 2022CHF365.11 (+8.73%)Earnings
- Tecan Group AG at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Full Year 2021 Tecan Group AG Earnings Call TranscriptMar 15, 2022CHF318.17 (-14.76%)Earnings
- Half Year 2021 Tecan Group AG Earnings Call TranscriptAug 18, 2021CHF539.36 (+2.28%)Earnings
- Tecan Group AG to Acquire Paramit Corp Call TranscriptJun 24, 2021
- Tecan Group AG at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Full Year 2020 Tecan Group AG Earnings Call TranscriptMar 16, 2021CHF386.83 (+4.10%)Earnings
- Tecan Group AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Half Year 2020 Tecan Group AG Earnings Call TranscriptAug 12, 2020CHF391.76 (-0.26%)Earnings
- Tecan Group AG at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Full Year 2019 Tecan Group AG Earnings Call TranscriptMar 17, 2020CHF275 (+14.97%)Earnings
- Half Year 2019 Tecan Group AG Earnings Call TranscriptAug 15, 2019CHF235 (-5.77%)Earnings
- Tecan Group AG Capital Markets Day TranscriptJun 06, 2019
- Tecan Group AG at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Full Year 2018 Tecan Group AG Earnings Call TranscriptMar 11, 2019Earnings
Tecan Group AG Capital Markets Day Transcript
So a very good morning, and welcome to Tecan's Capital Markets Day 2019. It's my sincere pleasure to welcome you all here in Männedorf. But also of course welcome, everyone, that listens live on the webcast and listens to the recordings afterwards. My name is Achim von Leoprechting, I'm the CEO of Tecan and it's my sincere pleasure to be in that position. And what we're trying to do today is give you an overview of Tecan as a company, but also our market environment and particularly give you some insights on how customers view the interaction with us now and potentially going forward.
So maybe just quickly to go through the agenda of the day. Today, we will have 3 major segments in which we will talk about application focus and the market segments that we're serving. So we're starting with the genomic applications where we talk about our own capabilities and our own progress, but we will also have a presentation by Ambry Genetics that will talk about their experiences with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)